Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01631552
Brief Title: Study of Sacituzumab Govitecan (IMMU-132) in Adults With Epithelial Cancer

First Submitted : June 26, 2012
First Submitted that Met QC Criteria : June 27, 2012
First Posted : June 29, 2012 (Estimate)

Results First Submitted : February 9, 2021
Results First Submitted that Met QC Criteria : March 10, 2021
Results First Posted : April 6, 2021

Last Update Submitted that Met QC Criteria : March 10, 2021
Last Update Posted : April 6, 2021